methylnitrosourea has been researched along with bexarotene in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bischoff, ED; Gottardis, MM; Heyman, RA; Lamph, WW; Shirley, MA; Wagoner, MA | 1 |
| Bischoff, ED; Gottardis, MM; Heyman, RA; Lamph, WW; Moon, TE | 1 |
| Bischoff, ED; Heyman, RA; Lamph, WW | 1 |
| Agarwal, VR; Bischoff, ED; Hermann, T; Lamph, WW | 1 |
| Bode, AM; Christov, K; Ericson, ME; Grubbs, CJ; Juliana, MM; Lubet, RA; Steele, VE; Szabo, E | 1 |
| Boring, D; Grubbs, CJ; Juliana, MM; Lubet, RA; Ruppert, JM; Steele, VE | 1 |
| Bojkova, B; Kajo, K; Karsnakova, R; Kassayova, M; Kiskova, T; Kubatka, P; Nosal, V; Orendas, P; Pec, M; Stollarova, N; Zihlavnikova, K | 1 |
| Garbow, JR; He, J; Higashikubo, R; Jones, LA; Lubet, RA; Mach, RH; Rowland, D; Shoghi, KI; Su, Y; Tu, Z; Wheeler, KT; Xu, J; Yan, Y; You, M | 1 |
8 other study(ies) available for methylnitrosourea and bexarotene
| Article | Year |
|---|---|
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Topics: Animals; Anticarcinogenic Agents; Bexarotene; Carcinogens; Drug Screening Assays, Antitumor; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Tetrahydronaphthalenes; Transcription Factors; Uterus | 1996 |
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Cell Division; Drug Screening Assays, Antitumor; Drug Synergism; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Retinoic Acid; Retinoid X Receptors; Tamoxifen; Tetrahydronaphthalenes; Transcription Factors | 1998 |
Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Carcinogens; Disease Progression; Female; Mammary Neoplasms, Experimental; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tamoxifen; Tetrahydronaphthalenes; Treatment Failure; Treatment Outcome | 1999 |
Induction of adipocyte-specific gene expression is correlated with mammary tumor regression by the retinoid X receptor-ligand LGD1069 (targretin).
Topics: Adaptor Protein Complex 2; Adaptor Protein Complex alpha Subunits; Adaptor Proteins, Vesicular Transport; Adipocytes; Animals; Anticarcinogenic Agents; Bexarotene; Carcinogens; Cell Differentiation; Cell Division; Clone Cells; Complement Factor D; Female; Gene Expression; Growth Inhibitors; Ligands; Lipoprotein Lipase; Mammary Neoplasms, Experimental; Membrane Proteins; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Serine Endopeptidases; Tetrahydronaphthalenes; Transcription Factors; Tumor Cells, Cultured | 2000 |
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bexarotene; Biomarkers, Tumor; Carcinogens; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Therapy, Combination; ErbB Receptors; Female; Gefitinib; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Methylnitrosourea; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Triazoles | 2008 |
Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Anticholesteremic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Atorvastatin; Bexarotene; Cell Proliferation; Diet; Disease Models, Animal; Female; Genes, erbB-2; Heptanoic Acids; Lovastatin; Mammary Neoplasms, Experimental; Methylnitrosourea; Mice; Mice, Knockout; Mice, Transgenic; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Retinoid X Receptors; Tamoxifen; Tetrahydronaphthalenes; Treatment Outcome; Tumor Suppressor Protein p53 | 2009 |
Melatonin enhanced bexarotene efficacy in experimental mammary carcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bexarotene; Carcinogens; Female; Mammary Neoplasms, Experimental; Melatonin; Methylnitrosourea; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Treatment Outcome | 2012 |
Quantitative receptor-based imaging of tumor proliferation with the sigma-2 ligand [(18)F]ISO-1.
Topics: Alkylating Agents; Animals; Anticarcinogenic Agents; Apoptosis; Benzamides; Bexarotene; Blotting, Western; Cell Proliferation; Female; Flow Cytometry; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Ligands; Mammary Neoplasms, Animal; Methylnitrosourea; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Receptors, sigma; Tetrahydronaphthalenes; Triazoles; Tumor Cells, Cultured | 2013 |